Solutions offered by the pharmacy profession to combat antimicrobial resistance (AMR) are to be advanced by a commission set up by the International Pharmaceutical Federation (FIP) during its FIP Virtual 2020 programme.
The FIP Commission on Antimicrobial Resistance will explore opportunities to increase the impact of pharmacy on AMR in all settings and scopes of practice. It will drive a new FIP Pharmacy AMR Roadmap to guide actions globally and regionally, which is currently being developed in consultation with members of FIP and will be published later this year.
The commission will also focus on the implementation of the FIP Development Goal on Antimicrobial Stewardship, which is one of 21 Development Goals launched by FIP earlier this week to support the transformation of the pharmacy profession around the world.
“The FIP Pharmacy AMR Roadmap will guide actions globally, sustaining momentum and tracking and evaluating progress of this global health priority for pharmacy. The FIP Development Goal on Antimicrobial Stewardship looks at the role of pharmacists, pharmaceutical scientists and pharmaceutical educators in reducing AMR. The new FIP Commission on Antimicrobial Resistance will facilitate the essential contribution of pharmacists to AMR action plans around the world, which include surveillance and monitoring of antimicrobial use and resistance, and antibiotics distribution and regulation,” said FIP CEO Dr Catherine Duggan.
She added: “AMR is a major public health threat that can have profound impacts on global, regional and national health care and economies. It is now more important than ever to act, because with the emergence of untreatable drug-resistant infections, we may soon find ourselves in yet another public health emergency. As with COVID-19, FIP and pharmacists globally are fully committed to being part of the solution. This work will culminate in a special Health Ministers Summit in 2023.”